中文
Company News
- BOC Sciences Returns to Drug Discovery Chemistry 2025, Seeking Broad Partnerships 3/28/2025
- BOC Sciences Innovates in Life Sciences with Advanced Long Non-coding RNA (lncRNA) Technol... 5/17/2024
- BOC Sciences to Present Its Novel Solutions at the 2024 TIDES USA Conference 4/29/2024
- BOC Sciences and Spaya Join Forces to Expand Chemical Offerings 12/22/2023
- BOC Sciences Celebrates Nobel Prize Awarded to Scientists Behind COVID-19 Vaccines 11/23/2023
- BOC Sciences at TIDES Europe 2023: Key Chemicals and XDC Platform to Be Exhibited 10/19/2023
- BOC Sciences Adds World Vaccine Congress Europe to Its 2023 Event Calendar 9/25/2023
- BOC Sciences Unveils Comprehensive Capabilities of Custom Peptide Drug Conjugate 5/9/2023
- BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Partners 5/5/2023
- BOC Sciences Rolled Out PEG GMP Manufacture Services for Broad Applications 9/23/2022
- BOC Sciences Promotion: Compound Docking Solutions for Drug Discovery 9/22/2022
- BOC Sciences 2022 Free Webinar: Viral RNA Modifications and Implications for Novel Therape... 9/21/2022
- Comprehensive Labeled Peptides with Stable Quality 9/21/2022
- BOC Sciences Outlines Its Contribution of Peptides to Cardiovascular Research 9/20/2022
- BOC Sciences Enzymatically Cleavable Linkers–a Promising Strategy in ADC Development 8/4/2022
- BOC Sciences Commitment at BIO 2022: From Concept to GMP Production 7/8/2022
- BOC Sciences New Promotes: Comprehensive Oligo Synthesis Service Package 7/7/2022
- BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development 7/6/2022
- BOC Sciences Contributes to a Large Portion of PseudoUridine Production for mRNA Vaccine R... 7/5/2022
- BOC Sciences Fermentation CDMO Services Prompt a New Era for Pharmaceutical Compound Produ... 7/4/2022